Trials / Completed
CompletedNCT04316884
Mechanisms for Organ Dysfunction in Covid-19
Uppsala Intensive Care Study of Mechanisms for Organ Dysfunction in Covid-19
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 380 (actual)
- Sponsor
- Uppsala University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to investigate organ dysfunction and biomarkers in patients with suspected or verified COVID-19 during intensive care at Uppsala University Hospital.
Detailed description
Consenting patients with suspected or verified SARS-COV-2 infection, COVID-19, will undergo daily blood, urine and sputum sampling during their stay in intensive care. Data on organ dysfunction will be collected through the electronic patient journal and electronic patient data management system. The collected samples will be analysed for a panel of potential biomarkers that will be correlated to organ dysfunction and clinical outcome.
Conditions
- COVID-19
- Organ Dysfunction Syndrome Sepsis
- Organ Dysfunction Syndrome, Multiple
- Septic Shock
- Acute Kidney Injury
- Acute Respiratory Distress Syndrome
Timeline
- Start date
- 2020-03-12
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2020-03-20
- Last updated
- 2026-01-12
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT04316884. Inclusion in this directory is not an endorsement.